Sphera Funds Management Ltd. Immatics N.V. Transaction History
Sphera Funds Management Ltd.
- $486 Million
- Q4 2024
A detailed history of Sphera Funds Management Ltd. transactions in Immatics N.V. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 921,111 shares of IMTX stock, worth $3.92 Million. This represents 1.35% of its overall portfolio holdings.
Number of Shares
921,111
Previous 721,111
27.73%
Holding current value
$3.92 Million
Previous $8.23 Million
20.4%
% of portfolio
1.35%
Previous 1.51%
Shares
14 transactions
Others Institutions Holding IMTX
# of Institutions
93Shares Held
82.1MCall Options Held
313KPut Options Held
377K-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.6MShares$45.2 Million0.05% of portfolio
-
Perceptive Advisors LLC New York, NY9.38MShares$40 Million2.23% of portfolio
-
Baker Bros. Advisors LP New York, NY7.28MShares$31 Million0.57% of portfolio
-
Rtw Investments, LP New York, NY6.54MShares$27.9 Million0.76% of portfolio
-
Vestal Point Capital, LP New York, NY6.28MShares$26.7 Million2.65% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $325M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...